网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
社区获得性肺炎病原学检测研究进展
作者:刘文  王西华 
单位:东南大学附属中大医院 呼吸科, 江苏 南京 210009
关键词:社区获得性肺炎 病原学检测 综述 
分类号:R372
出版年·卷·期(页码):2022·50·第十一期(1490-1494)
摘要:

社区获得性肺炎是常见的呼吸系统疾病,抗感染药物的应用,曾经有效控制了疾病进展并降低了其病死率。但近些年,由于新病原体的出现、病原体对抗感染药物的耐药、免疫受损宿主的增加,使得社区获得性肺炎的治疗出现了许多新问题。及时有效地对病原进行针对性治疗是决定其预后的关键。因此,病原学检测极为重要,作者就其检测方法及技术进展进行综述。

参考文献:

[1] SUN Y,LI H,PEI Z,et al.Incidence of community-acquired pneumonia in urban China:a national population-based study[J].Vaccine,2020,38(52):8362-8370.
[2] SONG J H,HUH K,CHUNG D R.Community-acquired pneumonia in the Asia-Pacific region[J].Semin Respir Crit Care Med,2016,37(6):839-854.
[3] 刘向欣.唐山地区成人社区获得性肺炎致病菌流行病学调查[J].天津医药,2013(12):1160-1164.
[4] CHARLES P G P,WHITBY M,FULLER A J,et al.The etiology of community-acquired pneumonia in Australia:why penicillin plus doxycycline or a macrolide is the most appropriate therapy[J].Clin Infect Dis,2008,46(10):1513-1521.
[5] YANG E,ALTES T,ANUPINDI S A.Early mycoplasma pneumoniae infection presenting as multiple pulmonary masses:an unusual presentation in a child[J].Pediatr Radiol,2008,38(4):477-480.
[6] 黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324.
[7] NIEDERMAN M S,MANDELL L A,ANZUETO A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis,assessment of severity,antimicrobial therapy,and prevention[J].Am J Respir Crit Care Med,2001,163(7):1730-1754.
[8] TORRES A,BLASI F,PEETERMANS W E,et al.The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe:a literature review[J].Eur J Clin Microbiol Infect Dis,2014,33(7):1065-1079.
[9] RUUSKANEN O,LAHTI E,JENNINGS L C,et al.Viral pneumonia[J].Lancet,2011,377(9773):1264-1275.
[10] 陈静,李晓光,王伟,等.成人社区获得性肺炎病原学特点分析[J].中华急诊医学杂志,2020,29(9):1210-1213.
[11] 胡晏宁,鲁炳怀.呼吸道感染性疾病病原学诊断的挑战与解决策略[J].中国临床新医学,2021,14(1):8-12.
[12] BASILE K,KOK J,DWYER D E.Point-of-care diagnostics for respiratory viral infections[J].Expert Rev Mol Diagn,2018,18(1):75-83.
[13] BARLAM T F,COSGROVE S E,ABBO L M,et al.Implementing an antibiotic stewardship program:guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America[J].Clin Infect Dis,2016,62(10):e51-e77.
[14] MOLINOS L,ZALACAIN R,MENENDEZ R,et al.Sensitivity,specificity,and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia[J].Ann Am Thorac Soc,2015,12(10):1482-1489.
[15] 贾红彦,董静,张宗德,等.结核分枝杆菌感染的免疫学检测技术研究进展及临床应用现状[J].中国防痨杂志,2022,44(7):720-726.
[16] 白晓晨.肺炎支原体血清学抗体检测现状与研究进展[J].国际儿科学杂志,2017,44(3):147-151.
[17] ZUMLA A,AL-TAWFIQ J A,ENNE V I,et al.Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs,advances,and future prospects[J].J Lancet Infect Dis,2014,14(11):1123-1135.
[18] ECHAVARRIA M,MARCONE D N,QUERCI M,et al.Clinical impact of rapid molecular detection of respiratory pathogens in patients with K acute respiratory infection[J].J Clin Virol,2018,108:90-95.
[19] KOO B,JIN C E,LEE T Y,et al.An isothermal,label-free,and rapid one-step rna amplification/detection assay for diagnosis of respiratory viral infections[J].Biosens Bioelectron,2017,90:187-194.
[20] AHN D G,SHIN H J,KIM M H,et al.Current status of epidemiology,diagnosis,therapeutics,and vaccines for novel coronavirus disease 2019(Covid-19)[J].J Microbiol Biotechnol,2020,30(3):313-324.
[21] LI C,SHI Y,YANG G,et al.Establishment of loop-mediated isothermal amplification for rapid detection of Pseudomonas aeruginosa[J].Exp Ther Med,2019,17(1):131-136.
[22] FONTANA L,STRASFELD L.Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient[J].Infect Dis Clin North Am,2019,33(2):523-544.
[23] CHENG M P,PAPENBURG J,DESJARDINS M,et al.Diagnostic testing for severe acute respiratory syndrome-related coronavirus-2:a narrative review[J].Ann Intern Med,2020,172(11):726-734.
[24] REZZA G,VALDARCHI C,PUZELLI S,et al.Respiratory viruses and influenza-like illness:a survey in the area of Rome,winter 2004-2005[J].Euro Surveill,2006,11(10):251-253.
[25] 王辉,曹彬.新的微生物诊断技术对呼吸道感染诊治的影响:现状与展望[J].中华检验医学杂志,2011,34:673-675.
[26] MAXAM A M,GILBERT W.A new method for sequencing DNA[J].Proc Natl Acad Sci U S A,1977,74(2):560-564.
[27] MARTINEZ M A,RUIZ M,ZUNINO E,et al.Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology[J].J Med Microbiol,2008,57:1491-1495.
[28] MURDOEH D R,ANDERSON T P,BEYNON K A,et al.Valuation of a PCR assay fordetection of Streptococcus pneumoniae in respiratory and nonrespiratory samplesfrom adults with community-acquired pneumonia[J].J Clin Microbiol,2003,41:63-66.
[29] NOLTE F S.Molecular diagnostics for detection of bacterial and viral pathogens incommunity-acquired pneumonia[J].Clin Infect Dis,2008,47(s3):S123-S126.
[30] SANGER F,NICKLEN S,COULSON A R.DNA sequencing with chain-terminating inhibitors 1977[J].Biotechnology,1992,24:104-108.
[31] NOVELLI G.Personalized genomic medicine[J].Intern Emerg Med,2010,5(Sl):S81-S90.
[32] FULLER C W,MIDDENDORF L R,BENNER S A,et al.The challenges of sequencing by synthesis[J].Nature Biotechnology,2009,27(11):1013.
[33] VOELKERDING K V,DAMES S A,DURTSCHI J D.Next-generation sequencing:from basic research to diagnostics[J].Clin Chem,2009,55(4):641-658.
[34] XIE F,DUAN Z,ZENG W,et al.Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia[J].BMC Infect Dis,2021,21(1):352.
[35] WU X,LI Y,ZHANG M,et al.Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing:a prospective multicenter study[J].Infect Dis Ther,2020,9(4):1003-1015.
[36] Jackson S A,Michael L K,Isha R P,et al.Rapid genomic-scale analysis of escherichia coli O104:H4 by using high-resolution alternative methods to next-generation sequencing[J].Appl Environ Microbiol,2011,78(5):1601-1605.
[37] BAO C J,CUI L B,ZHOU M H,et al.,Live-animal markets and in-fluenza A(H7N9) virus infection[J].N Engl J Med,2013,368(24):2337-2339.
[38] ZHOU P,YANG X L,WANG X G,et al.Addendum:a pneumonia outbreak associated with a new coronavirus of probable bat origin[J].Nature,2020,579(7798):270-273.
[39] GOODWIN S,MCPHERSON J D,MCCOMBIE W R.Coming of age:ten years of next-generation sequencing technologies[J].Nat Rev Gene,2016,17(6):333-351.
[40] MARDIS E R.Next-generation sequencing platforms[J].Annu Rev Anal Chem,2013,6:287-303.
[41] SHENDURE J,JI H.Next-generation DNA sequencing[J].Nat Biotechnol,2008,26(10):1135-1145.
[42] BOWERS J,MITCHELL J,BEER E,et al.Virtual terminator nucleotides for next-generation DNA sequencing[J].Nat Methods,2009,6(8):593-595.
[43] YE P,LUAN Y,CHEN K,et al.MethSMRT:an integrative database for DNA N6-methyladenine and N4-methylcytosine generated by single-molecular real-time sequencing[J].Nucleic Acids Res,2017,45(D1):D85-D89.
[44] 张春秀,肖华胜.基因芯片技术的发展和应用[J].生物产业技术,2010,3(5):75-80.
[45] 孙啸,王晔,何农跃,等.生物信息学在基因芯片中的应用[J].生物物理学报,2001,17(1):27-33.
[46] 吴丹桔.全自动免疫组织化学染色技术的应用进展[J].现代诊断与治疗,2013(13):2935-2936.
[47] 谢文林,唐翠兰,连家燕.病理组织芽生菌感染的特殊染色方法分析[J].中国组织化学与细胞化学杂志,2021,30(3):287-289.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752570 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541